|本期目录/Table of Contents|

[1]郭宇,魏玮,杨俭勤.代谢组学在病证相关中药复方研究中的应用[J].环球中医药,2015,8(11):1416-1420.[doi:10.3969/j.issn.1674-1749.2015.11.042]
　GUO Yu,WEI Wei,YANG Jian qin..Application of metabonomics in the study of disease integrating with syndrome and Chinese compound medicine[J].,2015,8(11):1416-1420.[doi:10.3969/j.issn.1674-1749.2015.11.042]
点击复制

代谢组学在病证相关中药复方研究中的应用()
     
分享到：

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第8卷
期数:
2015年11期
页码:
1416-1420
栏目:
综述
出版日期:
2015-11-06

文章信息/Info

Title:
Application of metabonomics in the study of disease integrating with syndrome and Chinese compound medicine
作者:
郭宇; 魏玮; 杨俭勤
100700北京中医药大学东直门医院 [郭宇（博士研究生）]；中国中医科学院望京医院脾胃病科（魏玮、杨俭勤）
Author(s):
GUO Yu;  WEI Wei;  YANG Jianqin.
Dongzhimen Hospital of Beijing University of Chinese Medicine， Beijing,100700, China
关键词:
代谢组学; 中药复方; 病证结合; 综述
Keywords:
Metabonomics; 〓Traditional Chinese compound medicine; 〓Disease and syndrome combination; 〓Review
分类号:
R289.5
DOI:
10.3969/j.issn.1674-1749.2015.11.042
文献标志码:
A
摘要:
代谢组学作为系统生物学的一个分支，是一种基于全局观点的整体性研究方法。基于代谢组学研究中药复方，既符合中医的整体观、动态观、辩证观等指导思想，又能与现代科学先进技术相结合，被广泛应用于病证相关领域研究，具有整体性、动态性等研究优势。
Abstract:
As a branch of systems biology, metabonomics is a holistic study method based on the overall viewpoint. In the study of modern traditional Chinese compound medicine, this method not only accords with guiding concepts in traditional Chinese medicine (TCM), such as holistic view, dynamic view and syndrome differentiation, but also combines TCM with modern scientific and advanced technology, which is widely used in studies related to disease integrating with syndrome and has prominent advantages in integrality and dynamics.

参考文献/References:

[1]Hu C, Xu G. Metabolomics and traditional Chinese medicine\[J\]. Trends in Analytical Chemistry, 2014, 61: 207214.
[4]许颖智, 张军平. 病证结合在中医辨证论治中的地位\[J\]. 中华中医药学刊, 2008, (11): 23622364.
[5]宋雅楠, 张永煜, 苏式兵. 代谢组学在“病证效”结合研究中的应用\[J\]. 世界科学技术（中医药现代化）, 2013, 15(4): 628633.
[6]周亚男. 基于“病证结合”模式的中医药临床疗效评价方法初探\[J\]. 世界科学技术（中医药现代化）, 2012, 14(2):14051407.
[7]王阶, 王永炎, 郭丽丽. 基于病证结合的中药组方模式研究\[J\]. 中国中药杂志, 2009, 34(1):10151017.
[8]陈可冀, 宋军. 病证结合的临床研究是中西医结合研究的重要模式\[J\]. 继续医学教育, 2007, 8(19):1215.
[9]罗国安, 梁琼麟, 王义明, 等. 中医药系统生物学发展及展望\[J\]. 中国天然药物, 2009, 7(4): 242248.
[10]Nicholson J K, Connelly J,Lindon J C, et al. Metabonomics: a platform for studying drug toxicity and gene function\[J\]. Nature reviews Drug discovery, 2002, 1(2): 153161.
[11]杜冠华. 中药复方有效成分组学研究\[J\]. 中成药, 2002, 24(11): 5658.
[12]张英丰, 董宇, 朱晓新. 中药复方药代动力学研究的方法与思考\[J\]. 中国天然药物, 2008, 6(5): 321324.
[13]徐璡, 许朝霞, 王又闻，等. 基于病证结合的中医证候规范化研究进展\[J\]. 中华中医药杂志, 2014, 29(1):1416.
[14]罗和古, 陈家旭. 代谢组学技术与中医证候的研究\[J\]. 中国中医药信息杂志, 2010, 14(5):35.
[15]Zheng X　F, Tian J, Liu P, et al. Analysis of the restorative effect of Buzhongyiqitang in the spleenqi deficiency rat model using 1HNMRbased metabonomics\[J\]. Journal of ethnopharmacology, 2014, 151(2): 912920.
[16]Wang P, Sun H,Lv H, et al. Thyroxine and reserpineinduced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLCHDMS\[J\]. Journal of pharmaceutical and biomedical analysis, 2010, 53(3): 631645.
[17]李伟霞, 黄美艳, 唐于平, 等. 基于代谢组学研究佛手散对血虚小鼠的养血补血作用机制\[J\]. 药学学报, 2013, 48(8): 13011306.
[18]王穆, 让蔚清, 张琪, 等. 四物汤对环磷酰胺所致血虚证治疗后的代谢组学研究\[J\]. 中国中药杂志, 2010, 35(5): 630634.
[19]〖JP3〗Liu Y T,Peng J B, Jia H M, et al. UPLCQ/TOF MS standardized 〖JP〗Chinese formula XinKeShu for the treatment of atherosclerosis in a rabbit model\[J\]. Phytomedicine, 2014, 21(11): 13641372.
[20]Liang X, Chen X, Liang Q, et al.Metabonomic study of Chinese medicine Shuanglong formula as an effective treatment for myocardial infarction in rats\[J\]. Journal of proteome research, 2010, 10(2): 790799.
[21]于晓红, 周亚滨, 孙静, 等. 养心汤对不稳定型心绞痛患者血浆代谢组学的影响\[J\]. 中国中西医结合杂志, 2013, 33(2): 191198.
[22]Dai W, Wei C, Kong H, et al.Effect of the traditional Chinese medicine tongxinluo on endothelial dysfunction rats studied by using urinary metabonomics based on liquid chromatography–mass spectrometry\[J\]. Journal of pharmaceutical and biomedical analysis, 2011, 56(1): 8692.
[23]彭树灵, 刘晓伟, 张真瑞, 等. 从代谢组学的角度探讨维胃方对大鼠实验性胃溃疡的疗效机制\[J\]. 中国中西医结合杂志, 2010, 30(10): 10731077.
[24]〖JP3〗Gou X, Tao Q,Feng Q, et al. Urinary metabonomics characterization 〖JP〗of liver fibrosis induced by CCl in rats and intervention effects of Xia Yu Xue Decoction\[J\]. Journal of pharmaceutical and biomedical analysis, 2013, 74: 6265.
[25]邱云平, 苏明明, 吴大正, 等. 金复康对大鼠大肠癌癌前病变的改善作用及尿液代谢物研究\[J\]. 中国中药杂志, 2008, 33(22): 26532657.
[26]〖JP3〗Zhang H, Fu P,Ke B, et al. Metabolomic analysis of biochemical 〖JP〗changes in the plasma and urine of collageninduced arthritis in rats after treatment with HuangLianJieDuTang\[J\]. Journal of ethnopharmacology, 2014, 154(1): 5564.
[27]Xue L, Wang Y, Liu L, et al. A 1HNMRbased metabonomics study of postmenopausal osteoporosis and intervention effects of erxian decoction in ovariectomized rats\[J\]. International journal of molecular sciences, 2011, 12(11): 76357651.
[28]Liu P,Duan J, Guo J, et al. Plasma metabolic profiling of normal and dysmenorrhea syndrome rats and the effects of XiangFuSiWu Decoction intervention\[J\]. Pharmaceutical biology, 2013, 52(5): 603613.
[29]Liu X J, Zhou Y Z, Li Z F, et al. Anti‐depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy\[J\]. Journal of Pharmacy and Pharmacology, 2012, 64(4): 578588.
[30]Gao X, Zheng X, Li Z, et al. Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry\[J\]. Journal of ethnopharmacology, 2011, 137(1): 690699.
[31]Su Z H, Li S Q,Zou G A, et al. Urinary metabonomics study of antidepressive effect of ChaihuShuGanSan on an experimental model of depression induced by chronic variable stress in rats\[J\]. Journal of pharmaceutical and biomedical analysis, 2011, 55(3): 533539.
[31]黎莉, 孙鹏, 梁琼麟, 等. 白香丹胶囊干预经前期综合征肝气逆证大鼠血清代谢组学研究\[J\]. 中成药, 2011, 33(5): 762767.
[32]Sun S, Dai J, Wang W, et al. Metabonomic Evaluation of ZHENG Differentiation and Treatment by Fuzhenghuayu Tablet in HepatitisBCaused Cirrhosis\[J\]. Evidencebased Complementary and Alternative Medicine, 2012, 2012(3): 453503.
[33]Nicholson J K, Lindon J C. Systems biology: metabonomics\[J\].Nature, 2008, 455(7216): 10541056.
[34]肖飞. 从循证医学到精准医学的思考\[J\]. 中华肾病研究电子杂志, 2014, (3):123128.
[35]Xie B G, Zhang Z R, Gong T, et al. Application of metabonomic strategy to discover an unreported active ingredient in LiuWeiDiHuang pills suppressing betaglucuronidase\[J\]. Analytical & Bioanalytical Chemistry, 2014, 407:609614.
[36]周本宏, 周静, 吴丽宁, 等. 天麻川芎对偏头痛模型大鼠尿液内源性物质代谢的影响\[J\]. 中国实验方剂学杂志, 2014, 20(3): 104108.
[37]Xu W, Wang H, Chen G, et al. 1H NMRbased metabonomics study on the toxicity alleviation effect of other traditional Chinese medicines in Niuhuang Jiedu tablet to realgar (As2S2)\[J\]. Journal of ethnopharmacology, 2013, 148(1): 8898.
[38]Wan J B,Bai X, Cai X J, et al. Chemical differentiation of DaChengQiTang, a Chinese medicine formula, prepared by traditional and modern decoction methods using UPLC/QTOFMSbased metabolomics approach\[J\]. Journal of pharmaceutical and biomedical analysis, 2013, 83: 3442.
[39]罗国安, 梁琼麟, 刘清飞,等. 整合化学物质组学的整体系统生物学——中药复方配伍和作用机理研究的整体方法论\[J\]. 世界科学技术：中医药现代化, 2007, 9(1):1015.
[40]Wei W, Li X, Hao J, et al. Proteomic analysis of functional dyspepsia in stressed rats treated with traditional Chinese medicine “Wei Kangning”\[J\]. Journal of gastroenterology and hepatology, 2011, 26(9): 14251433.
[41]丁莺, 吕宾, 孟立娜,等. 痛泻要方对内脏高敏感大鼠结肠黏膜蛋白质表达谱的影响\[J\]. 胃肠病学, 2012, 17(11):660664.
[42]〖JP3〗Taylor J, King R D,Altmann T, et al. Application of metabolomics 〖JP〗to plant genotype discrimination using statistics and machine learning\[J\]. Bioinformatics, 2002, 18(S2): S241S248.
[43]张爱华, 孙晖, 闫广利,等. 中医方证代谢组学——中医药研究的新策略\[J\]. 中国中药杂志, 2015,40(4)：569576.
[44]殷惠军, 黄烨. 病证结合动物模型的研究进展\[J\]. 中国中西医结合杂志, 2013, 33(1):810.
[45]Liu P, Liu S,Tian D, et al. The applications and obstacles of metabonomics in traditional chinese medicine\[J\]. EvidenceBased Complementary and Alternative Medicine, 2012, 2012(1): 945824.

相似文献/References:

[1]陆嫄,吴璐一,黄任佳,等.基于代谢组学技术研究艾灸治疗溃疡性结肠炎的思考[J].环球中医药,2013,6(06):450.
[2]宋芳娇,曾克武,王学美,等.中药复方有效成分组相关研究方法的研究进展[J].环球中医药,2012,5(12):951.
　SONG Fang-jiao,ZENG Ke-wu,WANG Xue-mei..Progress of research methods on active ingredient group of Chinese herbal formula[J].,2012,5(11):951.
[3]柏冬 王瑞海 刘丽梅.近十年中药药代动力学新技术新方法概述[J].环球中医药,2016,9(07):891.[doi:10.3969/j.issn.1674-1749.2016.07.040]
　BAI Dong,WANG Rui-hai,LIU Li-mei..Review on new technologies and methods of pharmacokinetics of traditional Chinese medicines in recent 10 years[J].,2016,9(11):891.[doi:10.3969/j.issn.1674-1749.2016.07.040]
[4]陈会 李新民 路岩莉 孙丹 聂坤 房艳艳 任艳艳.中药复方熄风胶囊对难治性癫痫大鼠多药耐药基因MDR1mRNA表达的影响[J].环球中医药,2017,10(07):692.[doi:10.3969/j.issn.1674-1749.2017.07.004]
　CHEN Hui,LI Xinmin,LU Yanli,et al.Effect of the Chinese herbal compound Xifeng capsule on expression of MDR1mRNA of intractable epilepsy rats[J].,2017,10(11):692.[doi:10.3969/j.issn.1674-1749.2017.07.004]
[5]董孟佳,许尤琪,方祯.中药复方治疗肝癌机理的实验研究进展[J].环球中医药,2017,10(10):1170.[doi:10.3969/j.issn.1674-1749.2017.10.036]
　DONG Mengjia,XU Youqi,FANG Zhen..Experimental research progress on the mechanism of Chinese herbal compound in treatment of liver cancer[J].,2017,10(11):1170.[doi:10.3969/j.issn.1674-1749.2017.10.036]
[6]郭宇,魏玮,杨俭勤.代谢组学在病证相关中药复方研究中的应用[J].环球中医药,2015,8(11):1416.[doi:10.3969/j.issn.1674-1749.2015.11.042]
　GUO Yu,WEI Wei,YANG Jian qin..Application of metabonomics in the study of disease integrating with syndrome and Chinese compound medicine[J].,2015,8(11):1416.[doi:10.3969/j.issn.1674-1749.2015.11.042]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 1900-01-01